[Value of immunotherapy in the perioperative treatment of localized muscle invasive bladder cancer].

Title:: [Value of immunotherapy in the perioperative treatment of localized muscle invasive bladder cancer].
Document type:: Article; English Abstract; Journal Article; Review
Author(s):: Lewerich, J; Schmid, S C; Gschwend, J E; Retz, M
Abstract:: Immune checkpoint inhibitors are standard of care in the treatment of metastatic and locally advanced urothelial cancer. Their use in perioperative treatment is currently under investigation as monotherapy as well as in combination with chemotherapy or radiation regimens. This article provides an overview of recent trials, current data as well as an outlook on future developments in the perioperative management of urothelial cancer.
Journal title abbreviation:: Urologie
Year:: 2023
Journal volume:: 62
Journal issue:: 3
Pages contribution:: 279-287
Fulltext / DOI:: doi:10.1007/s00120-022-01983-5
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/36449033
Print-ISSN:: 2731-7064
TUM Institution:: Klinik und Poliklinik für Urologie
BibTeX

Occurrences: